RG
DPLO

Redmile Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Redmile Group’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-957,155
Closed -$19.8M – 81
2017
Q3 		$19.8M Buy
+957,155
New +$16.2M 0.98% 33
2017
Q2 		– Sell
-1,254,342
Closed -$20M – 72
2017
Q1 		$20M Buy
1,254,342
+1,101,025
+718% +$15.9M 1.3% 29
2016
Q4 		$1.93M Buy
+153,317
New +$2.86M 0.17% 45
2016
Q1 		– Sell
-1,115,902
Closed -$38.2M – 62
2015
Q4 		$38.2M Buy
+1,115,902
New +$34.8M 2.86% 17

Other funds holding DPLO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Redmile Group's DPLO Position: Q4 2017 in Review

Redmile Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2017, closing a stake of 957,155 shares — an estimated $19.8M sold.

Redmile Group first reported a position in DPLO in Q4 2015 and held it in 4 quarters. The position peaked at $38.2M in Q4 2015. 200 funds tracked by Wall St. Rank hold DPLO as of Q4 2017.

  • Redmile Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2017 after selling out during the quarter.
  • Redmile Group sold 957,155 DIPLOMAT PHARMACY, INC. shares in Q4 2017, an estimated $19.8M.
  • Redmile Group first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 4 quarters.
  • Redmile Group's DIPLOMAT PHARMACY, INC. position peaked at $38.2M in Q4 2015.
  • 200 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2017.

Based on Redmile Group's 13F filing for Q4 2017, filed 14 Feb 2018.